BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8382877)

  • 1. Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival.
    Krishnan G; Vaughn WK; Capelli JP; Glass NR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1485-6. PubMed ID: 8382877
    [No Abstract]   [Full Text] [Related]  

  • 2. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 4. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
    Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
    Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
    [No Abstract]   [Full Text] [Related]  

  • 5. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

  • 6. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank.
    Carpenter CB; Goguen JE; Bradley JW; Turka LA; Cho SI; Milford EL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):663-4. PubMed ID: 2650215
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
    Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
    [No Abstract]   [Full Text] [Related]  

  • 10. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting HLA matching for kidney transplantation.
    Opelz G; Wujciak T; Mytilineos J; Scherer S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):173-5. PubMed ID: 8438263
    [No Abstract]   [Full Text] [Related]  

  • 12. How valid are risk factors for chronic transplant failure in renal transplant patients found in the literature with regard to our patients: results of a multivariate analysis.
    Kapsner T; Schneeberger H; Land W
    Transplant Proc; 1995 Feb; 27(1):878-80. PubMed ID: 7879217
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of HLA mismatching on the incidence of cytomegalovirus infection in living-related renal transplantations.
    Haberal M; Demirağ A; Turan M; Bilgin N; Büyükpamukçu N; Arslan G
    Transplant Proc; 1995 Oct; 27(5):2687-90. PubMed ID: 7482876
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of the donor age effect on kidney transplants.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
    Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
    Cicciarelli J; Terasaki P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposed HLA matching scheme for improved cadaveric kidney allocation.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S
    Transplant Proc; 1995 Feb; 27(1):61-3. PubMed ID: 7879117
    [No Abstract]   [Full Text] [Related]  

  • 19. Multivariate analysis of factors affecting cadaver kidney allograft survival in the chronic stage.
    Furukawa T; Kinukawa T; Hattori R; Ono Y; Katoh N; Fujita T; Nishiyama N; Matsuura O; Takeuchi N; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1565-7. PubMed ID: 8658787
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.